Luis Diaz

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi End of the century overview of skin blisters
    L A Diaz
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, USA
    Arch Dermatol 136:106-12. 2000
  2. ncbi Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem
    Luis A Diaz
    Department of Dermatology, University of North Carolina at Chapel Hill, North Carolina, USA
    J Invest Dermatol 123:1045-51. 2004
  3. ncbi The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus
    Luis A Diaz
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 128:667-75. 2008
  4. ncbi Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
    Ning Li
    Department of Dermatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA
    J Clin Invest 115:3440-50. 2005
  5. ncbi Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation
    Ruoyan Chen
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Immunol 169:3987-92. 2002
  6. ncbi Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid
    Lisa Leighty
    Department of Dermatology, University of North Carolina School of Medicine, 3100 Thurston Bowles, Chapel Hill, NC 27599, USA
    Arch Dermatol Res 299:417-22. 2007
  7. ncbi Role of FcRs in animal model of autoimmune bullous pemphigoid
    Minglang Zhao
    Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill 27599, USA
    J Immunol 177:3398-405. 2006
  8. ncbi A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3
    Luis A Arteaga
    Department of Dermatology, University of North Carolina at Chapel Hill, 27599, USA
    J Invest Dermatol 118:806-11. 2002
  9. ncbi Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis
    Hua En Lee
    Department of Dermatology, The University of North Carolina School of Medicine, Chapel Hill, NC 27599 7287, USA
    J Biol Chem 284:12524-32. 2009
  10. ncbi Role of different pathways of the complement cascade in experimental bullous pemphigoid
    Kelly C Nelson
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Clin Invest 116:2892-900. 2006

Research Grants

  1. TRAINING GRANT IN DERMATOLOGICAL RESEARCH
    Luis Diaz; Fiscal Year: 2006
  2. ETIOLOGY AND PATHOGENESIS OF PEMPHIGUS
    Luis Diaz; Fiscal Year: 2006
  3. PEMPHIGUS AND PEMPHIGOID
    Luis Diaz; Fiscal Year: 2007
  4. ETIOLOGY AND PATHOGENESIS OF PEMPHIGUS
    Luis A Diaz; Fiscal Year: 2010
  5. PEMPHIGUS AND PEMPHIGOID
    Luis Diaz; Fiscal Year: 2005
  6. ETIOLOGY AND PATHOGENESIS OF PEMPHIGUS
    Luis Diaz; Fiscal Year: 2001
  7. PEMPHIGUS AND PEMPHIGOID
    Luis A Diaz; Fiscal Year: 2010

Collaborators

  • Ning Li
  • D S Rubenstein
  • David A Dasher
  • Valeria Aoki
  • D Zillikens
  • Janet A Fairley
  • Mong Shang Lin
  • Stephen Clarke
  • Zhi Liu
  • Steven Shapiro
  • Meryem Bektas
  • Tanya N Mayadas
  • T B Nutman
  • Derry C Roopenian
  • Naftali Kaminski
  • Jian Ye
  • Cassian Sitaru
  • Paula Berkowitz
  • Ye Qian
  • Evandro A Rivitti
  • Kenneth W Kinzler
  • Bert Vogelstein
  • Ian Cheong
  • Chetan Bettegowda
  • Julio Hilario-Vargas
  • Puneet S Jolly
  • Hua En Lee
  • Bahjat F Qaqish
  • Carlo Rago
  • Victor E Velculescu
  • Minglang Zhao
  • Yardena Samuels
  • Shibin Zhou
  • David L Huso
  • Michael Chua
  • Donna A Culton
  • Elizabeth Lessey
  • Flor Evangelista
  • Vandir dos Santos
  • Gunter Hans-Filho
  • Rosicler Rocha Alvarez
  • Lisa Leighty
  • Michael P Chua
  • Kelly C Nelson
  • Xin Huang
  • Peiqi Hu
  • Erin K Pias
  • Tatiana Villas Boas Gabbi
  • Nishant Agrawal
  • Achim K Moesta
  • Luis A Arteaga
  • Ruoyan Chen
  • Jeffrey M Suchniak
  • Eugenio Andraca
  • Gunter Hans-Filhio
  • Phillip Prisayanh
  • Russel P Hall
  • Phillip S Prisayanh
  • Gunter Hans Filhio
  • Alex G Ortega-Loayza
  • Baktiar Karim
  • Alex G Ortega Loayza
  • Frank Diehl
  • Horacio Friedman
  • Iphis Campbell
  • Rosicler Rocha-Alvarez
  • Nickolas Papadopoulos
  • Guosheng Liu
  • Rick A Wetsel
  • Simon Warren
  • Manu Kohli
  • Jimmy Lin
  • Pamela R Schroeder
  • Xiaosong Zhang
  • Mary E Trimbeger
  • Giovanni Parmigiani
  • Stephen A Szabo
  • Laura DeLong
  • Jordan M Cummins
  • Christoph Lengauer
  • Jan J Enghild
  • Oleg Schmidt-Kittler
  • Mirian N Sotto
  • Vanessa Kodani
  • Charles G Drake
  • Mitsuaki Tatsumi
  • Richard L Wahl
  • Martin Pomper
  • Mohammad Abusedera
  • Isabela M Bernardelli

Detail Information

Publications46

  1. ncbi End of the century overview of skin blisters
    L A Diaz
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, USA
    Arch Dermatol 136:106-12. 2000
    ..Recent advances have uncovered the relevance of the keratinocyte cytoskeleton, the desmosome, the hemidesmosome, and extracellular matrix proteins in blister formation. A pathogenetic classification of blistering diseases is presented...
  2. ncbi Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem
    Luis A Diaz
    Department of Dermatology, University of North Carolina at Chapel Hill, North Carolina, USA
    J Invest Dermatol 123:1045-51. 2004
    ..In persons with the known HLA susceptibility alleles and living in endemic areas, a response to the EC1-2 domains may subsequently develop by epitope spreading with associated clinical signs of FS...
  3. ncbi The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus
    Luis A Diaz
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 128:667-75. 2008
    ..Recurrent environmental antigenic exposure may lead to IgM and IgG responses that trigger FS. JID JOURNAL CLUB ARTICLE: For questions, answers, and open discussion about this article please go to http://network.nature.com/group/jidclub...
  4. ncbi Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
    Ning Li
    Department of Dermatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA
    J Clin Invest 115:3440-50. 2005
    ..These data demonstrate that the therapeutic efficacy of HDIG treatment in the pemphigus and pemphigoid models is dependent on FcRn. Thus, FcRn is a promising therapeutic target for treating such IgG-mediated autoimmune diseases...
  5. ncbi Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation
    Ruoyan Chen
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Immunol 169:3987-92. 2002
    ..MCs play a major role in neutrophil recruitment into the dermis. Furthermore, Mphi-mediated neutrophil infiltration depends on MC activation/degranulation...
  6. ncbi Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid
    Lisa Leighty
    Department of Dermatology, University of North Carolina School of Medicine, 3100 Thurston Bowles, Chapel Hill, NC 27599, USA
    Arch Dermatol Res 299:417-22. 2007
    ..The development of two novel humanized mouse models for the first time has enabled study of disease mechanisms caused by BP autoantibodies, and presents an ideal in vivo system to test novel therapeutic strategies for disease management...
  7. ncbi Role of FcRs in animal model of autoimmune bullous pemphigoid
    Minglang Zhao
    Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill 27599, USA
    J Immunol 177:3398-405. 2006
    ..Results from this study establish that Fc gammaRIII plays a critical role in the activation of infiltrating neutrophils and the subsequent blistering in experimental BP...
  8. ncbi A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3
    Luis A Arteaga
    Department of Dermatology, University of North Carolina at Chapel Hill, 27599, USA
    J Invest Dermatol 118:806-11. 2002
    ..These results suggest that a subset of patients with pemphigus foliaceus and fogo selvagem have antibodies to desmoglein-3 that may be involved in the pathogenesis of their cutaneous disease...
  9. ncbi Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis
    Hua En Lee
    Department of Dermatology, The University of North Carolina School of Medicine, Chapel Hill, NC 27599 7287, USA
    J Biol Chem 284:12524-32. 2009
    ..Furthermore, these observations suggest that the earlier peak of p38MAPK activation is part of the mechanism leading to acantholysis, whereas the later peak of p38MAPK and apoptosis may not be essential for acantholysis...
  10. ncbi Role of different pathways of the complement cascade in experimental bullous pemphigoid
    Kelly C Nelson
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Clin Invest 116:2892-900. 2006
    ..These findings provide the first direct evidence to our knowledge that complement activation via the classical and alternative pathways is crucial in subepidermal blister formation in experimental BP...
  11. ncbi Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
    Zhi Liu
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Autoimmun 31:331-8. 2008
    ..The NC16A+/+ mice pretreated with mast cell activation blocker or depleted of complement or neutrophils become resistant to BP. These findings suggest that the humoral response in BP critically depends on innate immune system players...
  12. ncbi Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway: a step toward antigen-specific therapy?
    Zhi Liu
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 126:11-3. 2006
    ..Thus, blockade of this ligand-receptor interaction can prevent the development of antibody-mediated autoimmune diseases through different mechanisms...
  13. ncbi Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil
    Julio Hilario-Vargas
    Department of Dermatology, University of North Carolina at Chapel Hill, 27599, USA
    J Invest Dermatol 126:2044-8. 2006
    ....
  14. ncbi The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)
    Ning Li
    Department of Dermatology, University of North Carolina at Chapel Hill, 3100 Thurston Building, CB 7287 Chapel Hill, NC 27599, USA
    J Exp Med 197:1501-10. 2003
    ..Moreover, intramolecular epitope spreading may also modulate remissions and relapses of FS...
  15. ncbi Pemphigus antibody induced phosphorylation of keratinocyte proteins
    David S Rubenstein
    Department of Dermatology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7287, USA
    Autoimmunity 39:577-86. 2006
    ..Activation of p38 mitogen activated protein kinase may have a critical role in the acantholytic mechanism as inhibitors of p38MAPK block the ability of pemphigus IgG to induce blistering in pemphigus animal models...
  16. ncbi Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin
    Ning Li
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Immunol 182:711-7. 2009
    ..Collectively, these findings show that biochemical events of apoptosis are provoked in the epidermis of mice injected with PF autoantibodies. Caspase activation may contribute to acantholytic blister formation in PF...
  17. ncbi Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin
    Paula Berkowitz
    Department of Dermatology, The University of North Carolina School of Medicine, Chapel Hill, NC 27599 7287, USA
    Am J Pathol 173:1628-36. 2008
    ..Inhibition of p38 MAPK may be an effective strategy for the treatment of PF...
  18. ncbi Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus
    Ye Qian
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 129:2823-34. 2009
    ..We conclude that the anti-DSG1 response in FS is antigen driven and that selection for mutant anti-DSG1 B cells begins well before the onset of disease...
  19. ncbi The Thomsen-Friedenreich antigen-binding lectin jacalin interacts with desmoglein-1 and abrogates the pathogenicity of pemphigus foliaceus autoantibodies in vivo
    Ning Li
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 130:2773-80. 2010
    ..TF-specific binding ligands may have a potential therapeutic value for PF...
  20. ncbi Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid
    Zhi Liu
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    Blood 107:1063-9. 2006
    ..These data suggest that beta2 integrins play differential roles in experimental BP: LFA-1 is required for neutrophil recruitment, while Mac-1 mediates late neutrophil accumulation and apoptosis of infiltrating neutrophils...
  21. ncbi Synergy between a plasminogen cascade and MMP-9 in autoimmune disease
    Zhi Liu
    Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    J Clin Invest 115:879-87. 2005
    ..Thus, the Plg/plasmin system is epistatic to MMP-9 activation and subsequent dermal-epidermal separation in BP...
  22. ncbi Complement and cutaneous autoimmune blistering diseases
    Elizabeth Lessey
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    Immunol Res 41:223-32. 2008
    ....
  23. ncbi p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis
    Puneet S Jolly
    Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina 27599 7287, USA
    J Biol Chem 285:8936-41. 2010
    ..These data suggest that p38MAPK is capable of regulating PV IgG-mediated DSG3 internalization and that previously isolated mechanistic observations may be linked to a common pathway by which pemphigus autoantibodies lead to acantholysis...
  24. ncbi Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity
    Donna A Culton
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Autoimmun 31:311-24. 2008
    ....
  25. ncbi E-cadherin is an additional immunological target for pemphigus autoantibodies
    Flor Evangelista
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 128:1710-8. 2008
    ..The functional relevance of these anti-E-cadherin IgG autoantibodies detected in these pemphigus sera remains to be defined...
  26. ncbi Pemphigus foliaceus
    David Dasher
    Department of Dermatology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
    Curr Dir Autoimmun 10:182-94. 2008
    ..The study of the pathogenesis of PF and FS provides a unique opportunity to uncover insights that may contribute to our greater understanding of autoimmunity...
  27. ncbi Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients
    Ye Qian
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Immunol 178:5982-90. 2007
    ..We conclude that the potentially pathogenic IgG anti-Dsg response is restricted in V(H) use, is somatically mutated, and is Ag selected...
  28. ncbi p38MAPK inhibition prevents disease in pemphigus vulgaris mice
    Paula Berkowitz
    Department of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7287, USA
    Proc Natl Acad Sci U S A 103:12855-60. 2006
    ..We now report that p38MAPK inhibitors prevented PV blistering disease in vivo. Targeting the end-organ by inhibiting keratinocyte desmosome signaling may be effective for treating desmosome autoimmune blistering disorders...
  29. ncbi Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem)
    Bahjat F Qaqish
    Department of Biostatisitcs, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Invest Dermatol 129:110-8. 2009
    ..Identifying individuals during preclinical FS will enhance our ability to identify the etiological agent(s) triggering FS...
  30. ncbi Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization
    Paula Berkowitz
    Department of Dermatology, University of North Carolina-Chapel Hill School of Medicine, 27599, USA
    J Biol Chem 280:23778-84. 2005
    ..Targeting desmosome signaling via inhibition of p38MAPK and HSP27 phosphorylation may provide novel treatments for PV and other desmosome-associated blistering diseases...
  31. ncbi Humoral autoimmunity in pemphigus
    Erin K Pias
    Department of Dermatology, University of North Carolina at Chapel Hill, 3100 Thurston Building, Chapel Hill, NC 27599, USA
    Autoimmunity 37:283-6. 2004
  32. ncbi T cell receptor Beta chain gene usage in endemic pemphigus foliaceus (fogo selvagem)
    Achim K Moesta
    Department of Dermatology, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Invest Dermatol 119:377-83. 2002
    ..Furthermore, T cell receptor beta variable region and beta joining usage did not appear to be random, but oligoclonal in nature, with some preference shown for T cell receptor beta variable region 5S1 and T cell receptor BJ2S5...
  33. ncbi Pemphigus foliaceus with neutrophilic spongiosis evolving to an atypical pemphigus phenotype
    Tatiana Villas Boas Gabbi
    Department of Dermatology, , , Brazil
    J Am Acad Dermatol 51:1012-3. 2004
    ..Interestingly, his autoantibody profile, tested by immunofluorescence, immunoblotting, enzyme-linked immunosorbent assay, and immunoprecipitation revealed exclusive IgG anti-desmoglein 1 antibodies in all phases of the disease...
  34. ncbi Pharmacologic and toxicologic evaluation of C. novyi-NT spores
    Luis A Diaz
    Howard Hughes Medical Institute, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA
    Toxicol Sci 88:562-75. 2005
    ..However, there was no laboratory or histopathologic evidence of sepsis, and the toxicity could be effectively controlled by simple hydration...
  35. ncbi Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem)
    Valeria Aoki
    Department of Dermatology, University of Sao Paulo, Sao Paulo, Brazil
    J Investig Dermatol Symp Proc 9:34-40. 2004
    ..These findings suggest that the environmental antigen(s) triggering the autoimmune response in FS may be linked to exposure to hematophagous insects...
  36. ncbi Endemic pemphigus vulgaris
    Rosicler Rocha Alvarez
    Department of Dermatology, Universidade Federal de Brasilia, Brasilia, Distrito Federal
    Arch Dermatol 143:895-9. 2007
    ..Our objective was to characterize antidesmoglein 3 and antidesmoglein 1 autoantibody profiles in these unique patients who reside in Goiânia and Brasilia, Brazil, known endemic regions of fogo selvagem...
  37. ncbi Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin
    Paula Berkowitz
    J Invest Dermatol 128:738-40. 2008
  38. ncbi IgM-mediated epidermolysis bullosa acquisita
    Jeffrey M Suchniak
    Arch Dermatol 138:1385-6. 2002
  39. ncbi Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen
    Luis A Diaz
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, 48109, USA
    J Lab Clin Med 142:149-57. 2003
    ..After such interactions T-cells can develop secondary responses in autologous interactions based on retention of minute amounts of SAg. Such interactions may have important implications for xenotransplantation...
  40. ncbi Immunopathological mechanisms of acantholysis in pemphigus vulgaris: an explanation by ultrastructural observations
    Zhi Liu
    J Invest Dermatol 122:XIII-XIV. 2004
  41. ncbi Mutant PIK3CA promotes cell growth and invasion of human cancer cells
    Yardena Samuels
    The Sidney Kimmel Comprehensive Cancer Center and The Howard Hughes Medical Institute, The Johns Hopkins University Medical Institutions, Baltimore, MD 21231, USA
    Cancer Cell 7:561-73. 2005
    ..Treatment with the PI3K inhibitor LY294002 abrogated PIK3CA signaling and preferentially inhibited growth of PIK3CA mutant cells. These data have important implications for therapy of cancers harboring PIK3CA alterations...
  42. ncbi Bacteriolytic therapy can generate a potent immune response against experimental tumors
    Nishant Agrawal
    Howard Hughes Medical Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Proc Natl Acad Sci U S A 101:15172-7. 2004
    ..Similar effects were observed in rabbits with intrahepatic tumors. It was particularly notable that the induced immune response, when combined with the bacteriolytic effects of C. novyi-NT, could eradicate large established tumors...
  43. ncbi The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT
    Chetan Bettegowda
    The Howard Hughes Medical Institute, The Ludwig Center for Cancer Genetics and Therapeutics, The Sidney Kimmel Comprehensive Cancer Center, Department of Pharmacology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Nat Biotechnol 24:1573-80. 2006
    ..Through this analysis, we found that C. novyi-NT spores contained mRNA and that the spore transcripts were distinct from those in vegetative forms of the bacterium...
  44. ncbi Serial assessment of human tumor burdens in mice by the analysis of circulating DNA
    Carlo Rago
    The Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute, Baltimore, Maryland, USA
    Cancer Res 67:9364-70. 2007
    ..A marked, transient spike in circulating human tumor DNA occurred immediately after cytotoxic therapy or surgery. This simple assay may find broad utility in target validation studies and preclinical drug development programs...
  45. ncbi Rituximab and pemphigus--a therapeutic advance
    Luis A Diaz
    N Engl J Med 357:605-7. 2007
  46. ncbi A bacterial protein enhances the release and efficacy of liposomal cancer drugs
    Ian Cheong
    Howard Hughes Medical Institute and the Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA
    Science 314:1308-11. 2006
    ..This protein could potentially be incorporated into diverse experimental approaches for the specific delivery of chemotherapeutic agents to tumors...

Research Grants21

  1. TRAINING GRANT IN DERMATOLOGICAL RESEARCH
    Luis Diaz; Fiscal Year: 2006
    ..This competitive grant application requests funding to support the training at the UNC Dermatology Department of the next generation of dermatological investigators. ..
  2. ETIOLOGY AND PATHOGENESIS OF PEMPHIGUS
    Luis Diaz; Fiscal Year: 2006
    ..It is likely that characteristics of the mechanism of autoimmunity for FS will be shared with other human autoimmune diseases and what we learn from ES will be applicable to the study of human autoimmunity. ..
  3. PEMPHIGUS AND PEMPHIGOID
    Luis Diaz; Fiscal Year: 2007
    ..Finally, we will generate human anti-idiotypic antibodies by phage display technology and attempt to block binding of PV or PF/FS autoantibodies to their target epidermal antigens, thus preventing disease. ..
  4. ETIOLOGY AND PATHOGENESIS OF PEMPHIGUS
    Luis A Diaz; Fiscal Year: 2010
    ..At the completion of this application we will have a better understanding of other human autoimmune diseases like lupus erythematosus, rheumatoid arthritis, thyroiditis, and others. ..
  5. PEMPHIGUS AND PEMPHIGOID
    Luis Diaz; Fiscal Year: 2005
    ..Similar studies will be performed with anti-dsg3 autoantibodies in PV. These studies may lead to new therapies for these serious cutaneous autoimmune diseases. ..
  6. ETIOLOGY AND PATHOGENESIS OF PEMPHIGUS
    Luis Diaz; Fiscal Year: 2001
    ..Information obtained from these studies should be relevant in understanding the onset and development of FS and other human autoimmune diseases. ..
  7. PEMPHIGUS AND PEMPHIGOID
    Luis A Diaz; Fiscal Year: 2010
    ..Finally, we will generate human anti-idiotypic antibodies by phage display technology and attempt to block binding of PV or PF/FS autoantibodies to their target epidermal antigens, thus preventing disease. ..